Quick Answer
KIORA PHARMACEUTICALS INC reported Net Income Loss of -$10.84 million for the year ending 2025.
- KIORA PHARMACEUTICALS INC showed a decrease of -401.4% in Net Income Loss from 2024 to 2025.
- This data is from KIORA PHARMACEUTICALS INC's annual report (Form 10-K), filed with the SEC on March 25, 2026.
- XBRL data for this metric is available from 2017 to 2025 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 9 years of available data (2017 to 2025), KIORA PHARMACEUTICALS INC's Net Income Loss has grown by 18.0%.
- Historical annual values: Fiscal year 2025: -$10.84 million | Fiscal year 2024: $3.59 million | Fiscal year 2023: -$12.51 million | Fiscal year 2022: -$13.58 million | Fiscal year 2021: -$13.77 million | Fiscal year 2020: -$8.09 million | Fiscal year 2019: -$7.10 million | Fiscal year 2018: -$10.81 million | Fiscal year 2017: -$13.22 million.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: